HOUSTON (Sept. 19, 2014) OrthoAccel® Technologies, Inc. is pleased to announce that AcceleDent Aura won a Silver Stevie Award in the 12th Annual American Business Awards (ABA) Competition in the category of New Product of the Year – Health and Pharmaceuticals. Manufactured by OrthoAccel, AcceleDent® Aura is the first and only FDA-cleared, noninvasive medical device that speeds up orthodontic treatment by as much as 50 percent with just 20 minutes of daily use.
The ABA competition, also known as The Stevie® Awards, honors and generates public recognition of achievements and positive contributions from every facet of business, such as new product development, marketing, information technology and web development, to name a few.
“As the leader of the accelerated orthodontic industry, we are elated that our company and product, AcceleDent Aura, has been recognized for innovation alongside world-class companies like GE, American Express, Toshiba and Sony,” said Mike Lowe, president and CEO of OrthoAccel. “Never before has there been a noninvasive solution to accelerating orthodontic treatment and, because of that, leading orthodontists are calling AcceleDent a game-changing product in our industry.”
AcceleDent was one of more than 3,300 nominations submitted in the annual ABA competition, which is judged by 130 business professionals from varying industries. During preliminary judging, each entry is reviewed and rated by no fewer than five judges and it must receive an average score of at least seven on a 10 scale to become a finalist. The judges then selected this year’s Gold, Silver and Bronze Stevie Award winners.
Winners were announced in September at an awards banquet in San Francisco with more than 260 business executives in attendance.
Patients, orthodontists or staff members interested in learning more about AcceleDent’s groundbreaking technology can visit AcceleDent.com.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel developed and sells AcceleDent® Aura, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses via SoftPulse Technology® as a complement to existing orthodontic treatment. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via firstname.lastname@example.org.